Oscar Health, Inc. Cash and Restricted Cash
Oscar Health, Inc. (OSCR) had Cash and Restricted Cash of $4.10 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.10B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.83B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.80B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.17B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $4.10B 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.83B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.80B 10-Q · filed 2026-08-07 |
| 2025-09-30 | $2.17B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.62B 10-Q · filed 2026-08-07 |
| 2025-03-31 | $2.26B 10-Q · filed 2026-05-07 |
| 2024-12-31 | $1.55B 10-Q · filed 2026-08-07 |
| 2024-09-30 | $1.23B 10-Q · filed 2025-11-06 |
| 2024-06-30 | $2.29B 10-Q · filed 2025-08-07 |
| 2024-03-31 | $2.25B 10-Q · filed 2025-05-08 |
| 2023-12-31 | $1.89B 10-K · filed 2026-02-13 |
| 2023-09-30 | $1.42B 10-Q · filed 2024-11-07 |
| 2023-06-30 | $2.34B 10-Q · filed 2024-08-07 |
| 2023-03-31 | $2.13B 10-Q · filed 2024-05-07 |
| 2022-12-31 | $1.58B 10-K · filed 2026-02-13 |
| 2022-09-30 | $2.14B 10-Q · filed 2023-11-07 |
| 2022-06-30 | $2.38B 10-Q · filed 2023-08-09 |
| 2022-03-31 | $2.09B 10-Q · filed 2023-05-10 |
| 2021-12-31 | $1.13B 10-K · filed 2025-02-20 |
| 2021-09-30 | $1.10B 10-Q · filed 2022-11-09 |
| 2021-06-30 | $1.69B 10-Q · filed 2022-08-12 |
| 2021-03-31 | $2.34B 10-Q · filed 2022-05-12 |
| 2020-12-31 | $843.11M 10-K · filed 2024-02-15 |
| 2020-09-30 | $354.21M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $1.01B 10-Q · filed 2021-08-13 |
| 2020-03-31 | $508.18M 10-Q · filed 2021-05-14 |
| 2019-12-31 | $353.38M 10-K · filed 2023-02-24 |
| 2018-12-31 | $370.36M 10-K · filed 2022-02-25 |